Treatment advances in borderline personality disorder

Psychiatric Annals

Volumn 42, Issue 2, 2012, Pages 59-64

  Nelson, Katharine J ^a   Charles Schulz, S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857812228     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20120124-06     Document Type: Article

References (34)

1. Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry. 2009;166(5):530-539.
2. Torgerson S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58(6):590-596.
3. Grant B, Chou S, Goldstein R, et al. Prevalence, correlates, disability and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-545.
4. Torgersen S, Lygren S, Øien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000;41(6):416-425.
5. Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry. 2007;164(6):929-935.
6. Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011;68(8):827-837.
7. Grant JE, Correia S, Brennan-Krohn T, Malloy PF, Laidlaw DH, Schulz SC. Frontal white matter integrity in borderline personality disorder with self-injurious behavior. J Neuropsychiatry Clin Neurosci. 2007;19(4):383-390.
8. New AS, Hazlett EA, Buchsbaum MS, et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology. 2007;32(7):1629-1640.
9. Schulz SC, Zanarini MC, Bateman A, et al. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. Br J Psychiatry. 2008;193(6):485-492.
10. McMain SF, Links PS, Gnam WH, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1365-1374.
11. American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry. 2001;158(10S):1-52.
12. National Collaborating Centre for Mental Health. Borderline Personality Disorder: the NICE Guideline for Treatment and Management. National Clinical Practice Guideline Number 78. London, United Kingdom: The British Psychological Society and The Royal College of Psychologists; 2009.
13. Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010;71(1):14-25.
14. Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Pharmacological interventions for borderline personality disorder: Cochrane Database of Syst Rev. 2010;(6): CD005653.
15. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifl uoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45(2):111-9.
16. Soloff PH, George A, Nathan RS, Schulz PM, Perel JM. Behavioral dyscontrol in borderline patients treated with amitriptyline. Psychopharmacol Bull. 1987;23(1):177-181.
17. Nelson KJ, Schulz SC. Pharmacologic Treatment of Borderline Personality Disorder. Curr Psychiatr. 2011;10(8):30-40.
18. Linehan MM, McDavid JD, Brown MZ, Sayrs JH, Gallop RJ. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry. 2008;69(6):999-1005.
19. Soler J, Pascual JC, Campins J, et al. Doubleblind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry. 2005;162(6):1221-1224.
20. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: The Guilford Press; 1993.
21. Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757-766.
22. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48(12):1060-1064.
23. Koons CR, Robins CJ, Tweed JL, et al. Effi cacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behav Ther. 2001;32(2):371-390.
24. Linehan MM, Schmidt H 3rd, Dimeff LA, Craft JC, Kanter J, Comtois KA. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict. 1999;8(4):279-292.
25. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1355-1364.
26. Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry. 2008;165(5):631-638.
27. Blum N, St John D, Pfohl B, Stuart S, McCormick B, Allen J, Arndt S, Black DW. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry. 2008;165(4):468-478.
28. Kernberg OF. Technical considerations in the treatment of borderline personality organization. J Am Psychoanal Assoc. 1976;24(4):795-829.
29. Doering S, Hörz S, Rentrop M, et al. Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. Br J Psychiatry. 2010;196(5):389-395.
30. Giesen-Bloo J, van Dyck R, Spinhoven P, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63(6):649-658.
31. National Education Alliance for Borderline Personality Disorder Family Connections website. www.borderlinepersonalitydisorder. com/family-connections. Accessed Jan. 26, 2012.
32. Treatment and Research Advancements National Association for Personality Disorder website. www.tara4bpd.org. Accessed Jan. 26, 2012.
33. Gunderson J. Borderline Personality Disorder: A Clinical Guide. 2nd ed. American Psychiatric Publishing, Inc. Arlington, VA. 2008.
34. Schulz S, Rafferty P. Combined medication and Dialectical Behavior Therapy for Borderline Personality Disorder. Soc Work Ment Health. 2008;6(1 and 2):133-144.